点击显示 收起
Nov. 7, 2006 (Philadelphia) -- A newer method to deliver radiation to men with early prostate cancer appears to cause fewer serious side effects than the older radiation seed implant therapy, according to one of the first head-to-head comparisons of the two techniques.
In particular, men treated with the newer method, called intensity modulated radiation therapy, or IMRT, were less likely to need catheters to help them urinate, according to the study.
In the study, researchers at Fox Chase Cancer Center in Philadelphia compared results in 216 men treated with IMRT to 158 men treated with radiation seed implant therapy.
All the men in the study had early cancer at low risk of spreading beyond the prostate gland.
In IMRT, multiple radiation beams are focused at the prostate from many directions.
A computerized program allows doctors to adjust both the strength and the intensity of the beams, so that more radiation is blasted at the tumor and less at critical surrounding organs such as the bladder and rectum.
In radiation seed implant therapy, called brachytherapy, surgeons implant tiny radioactive seeds into the prostate gland. The seeds deliver high-dose radiation directly to the prostate for a predetermined length of time.
Bladder Problems
Among the findings, presented here at the annual meeting of the American Society for Therapeutic Radiology and Oncology: